My aim is to use advanced Neuroimaging to further our understanding of the pathophysiology of brain disorders, in particular Epilepsy, but also Sleep disorders, Schizophrenia, the Dementias. In the case of my main research interest (Epilepsy) it is to red
Prof Hunter is a rheumatologist engaged in clinical osteoarthritis research. In his current work he is investigating a number of key elements in osteoarthritis including (but not limited to) the epidemiology of osteoarthritis, genetic epidemiology of osteoarthritis, the role of biomarkers in understanding OA etiopathogenesis, the role of non-pharmacologic options in disease management and the application of imaging to better understand structure and function with application to both epidemiologi ....Prof Hunter is a rheumatologist engaged in clinical osteoarthritis research. In his current work he is investigating a number of key elements in osteoarthritis including (but not limited to) the epidemiology of osteoarthritis, genetic epidemiology of osteoarthritis, the role of biomarkers in understanding OA etiopathogenesis, the role of non-pharmacologic options in disease management and the application of imaging to better understand structure and function with application to both epidemiologic research and clinical trials.Read moreRead less
I use multidisciplinary and neuroimaging approaches to understand how the biochemistry of the brain affects how the brain functions in health and disease. This basic science underpins treatment approaches and furthers our understanding of a wide range of brain disorders.
I am a biomechanical engineer researching the effects of mechanical loads on the human body, both at physiological and injurious loading levels. This research leads to both fundamental data on tissue properties and the physiological response, and also to
I am a neuroscientist using robust statistical methods to identify effective neuroprotectants for stroke. I am examining the use of neuroprotection and novel imaging approaches to extend the utility of thrombolysis, and testing the hypothesis that neuropr
Receptor Tyrosine Kinase Function As Molecular Target In Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$415,788.00
Summary
As molecular cell biologist and protein chemist my motivation for research is to tackle metastatic cancer, one of the principle health burdens of the 21 century. Over the next five years I will lead R&D programs with national and international collaborators that will generate new diagnostic approaches and insights in basic and translational research. These will allow us to develop anti-cancer drugs, which target several of the mechanisms that are active in metastatic cancers.
I am an applied respiratory physiologist investigating the pathophysiology of upper airway dysfunction in individuals with sleep-disordered breathing and the application of exercise physiology principles to the development of novel rehabilitation methods